NEW YORK (GenomeWeb) – Alere announced today that it has received 510(k) clearance from the US Food and Drug Administration for a point-of-care isothermal nucleic acid amplification test that detects respiratory syncytial virus infection in children and adults from nasopharyngeal swab samples in 13 minutes or less.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.